Literature DB >> 24923581

What's new in status epilepticus?

Andrea O Rossetti1, Thomas P Bleck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24923581     DOI： 10.1007/s00134-014-3363-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  Ketogenic diet for adults in super-refractory status epilepticus.

Authors:  Kiran T Thakur; John C Probasco; Sara E Hocker; Kelly Roehl; Bobbie Henry; Eric H Kossoff; Peter W Kaplan; Romergryko G Geocadin; Adam L Hartman; Arun Venkatesan; Mackenzie C Cervenka
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

2.  Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.

Authors:  Vincent Alvarez; Jean-Marie Januel; Bernard Burnand; Andrea O Rossetti
Journal:  Epilepsia       Date:  2011-04-11       Impact factor: 5.864

3.  The established status epilepticus trial 2013.

Authors:  Thomas Bleck; Hannah Cock; James Chamberlain; James Cloyd; Jason Connor; Jordan Elm; Nathan Fountain; Elizabeth Jones; Daniel Lowenstein; Shlomo Shinnar; Robert Silbergleit; David Treiman; Eugen Trinka; Jaideep Kapur
Journal:  Epilepsia       Date:  2013-09       Impact factor: 5.864

4.  Treatment deviating from guidelines does not influence status epilepticus prognosis.

Authors:  Andrea O Rossetti; Vincent Alvarez; Jean-Marie Januel; Bernard Burnand
Journal:  J Neurol       Date:  2012-08-17       Impact factor: 4.849

5.  Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Peter W Kaplan; Stephan Rüegg
Journal:  Neurology       Date:  2013-12-06       Impact factor: 9.910

6.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

7.  Ketamine use in the treatment of refractory status epilepticus.

Authors:  Andrea S Synowiec; Deepinder S Singh; Vamsi Yenugadhati; James P Valeriano; Carol J Schramke; Kevin M Kelly
Journal:  Epilepsy Res       Date:  2013-01-29       Impact factor: 3.045

8.  Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.

Authors:  C Kellinghaus; S Berning; F Stögbauer
Journal:  Acta Neurol Scand       Date:  2013-08-13       Impact factor: 3.209

9.  Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.

Authors:  Nicolas Gaspard; Brandon Foreman; Lilith M Judd; James N Brenton; Barnett R Nathan; Blathnaid M McCoy; Ali Al-Otaibi; Ronan Kilbride; Ivan Sánchez Fernández; Lucy Mendoza; Sophie Samuel; Asma Zakaria; Giridhar P Kalamangalam; Benjamin Legros; Jerzy P Szaflarski; Tobias Loddenkemper; Cecil D Hahn; Howard P Goodkin; Jan Claassen; Lawrence J Hirsch; Suzette M Laroche
Journal:  Epilepsia       Date:  2013-06-12       Impact factor: 5.864

Review 10.  The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy.

Authors:  Monica Ferlisi; Simon Shorvon
Journal:  Brain       Date:  2012-05-09       Impact factor: 13.501
View more
  8 in total

Review 1.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

Review 2.  What's new in refractory status epilepticus?

Authors:  Stephane Legriel; Mauro Oddo; Gretchen M Brophy
Journal:  Intensive Care Med       Date:  2016-08-20       Impact factor: 17.440

3.  The SAMUKeppra study in prehospital status epilepticus: lessons for future study.

Authors:  Andrew C Schomer; Jaideep Kapur
Journal:  Ann Transl Med       Date:  2016-12

4.  Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.

Authors:  Vincent Alvarez; Jong Woo Lee; Frank W Drislane; M Brandon Westover; Jan Novy; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

5.  Prognostic significance of specific EEG patterns after cardiac arrest in a Lisbon Cohort.

Authors:  Beatriz Guedes; Manuel Manita; Ana Rita Peralta; Ana Catarina Franco; Luís Bento; Carla Bentes
Journal:  Clin Neurophysiol Pract       Date:  2020-07-30

6.  Functional outcome of prolonged refractory status epilepticus.

Authors:  Alexandre Lai; Hervé D Outin; Julien Jabot; Bruno Mégarbane; Stéphane Gaudry; Rémi Coudroy; Guillaume Louis; Francis Schneider; Nicolas Barbarot; Antoine Roch; Nicolas Lerolle; David Luis; François Fourrier; Anne Renault; Laurent Argaud; Tarek Sharshar; Sébastien Gibot; Pierre-Edouard Bollaert
Journal:  Crit Care       Date:  2015-04-30       Impact factor: 9.097

Review 7.  Optimizing sedation in patients with acute brain injury.

Authors:  Mauro Oddo; Ilaria Alice Crippa; Sangeeta Mehta; David Menon; Jean-Francois Payen; Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Crit Care       Date:  2016-05-05       Impact factor: 9.097

8.  Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study.

Authors:  Paula Rodrigues Sanches; Thiago Domingos Corrêa; Taissa Ferrari-Marinho; Pedro Vicente Ferreira Naves; Carol Ladeia-Frota; Luís Otávio Caboclo
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.